These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Polypeptides from influenza virus, obtained in the presence of high concentrations of rimantadine]. Boreko EI, Pavlova NI, Votiakov VI. Vopr Virusol; 1998; 43(6):270-4. PubMed ID: 10488531 [Abstract] [Full Text] [Related]
3. [Antiviral action of sodium selenite and its combination with remantadine]. Abdullaev II, Sycheva IV, Lazymova ZA, Veselovskaia TV, Abdullaev FI. Vopr Virusol; 1987; 32(6):670-5. PubMed ID: 3445584 [Abstract] [Full Text] [Related]
11. [Prevention of the formation of a mutant influenza A virus resistant to rimantadine (alpha-methyl-1-adamantanemethylamine hydrochloride) by using ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide)]. Pushkarskaia NL, L'vov ND, Galegov GA. Vopr Virusol; 1980 May; (3):303-6. PubMed ID: 7434722 [Abstract] [Full Text] [Related]
14. Rapid method for the detection of synergism in combinations of antiviral substances. Rada B, Hanusovská T. Acta Virol; 1987 Mar; 31(2):126-37. PubMed ID: 2886021 [Abstract] [Full Text] [Related]
15. Anti-influenza virus activity of the compound LY253963. Hayden FG, Rollins BS, Hay AJ. Antiviral Res; 1990 Jul; 14(1):25-38. PubMed ID: 2080866 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Rees WA, Harkins JD, Lu M, Holland RE, Lehner AF, Tobin T, Chambers TM. Am J Vet Res; 1999 Jul; 60(7):888-94. PubMed ID: 10407485 [Abstract] [Full Text] [Related]